| Authors: |
Lorenzen E; Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Contreras V; Université Paris-Saclay, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Olsen AW; Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Andersen P; Novo Nordisk Foundation, Infectious Disease, Hellerup, Denmark., Desjardins D; Université Paris-Saclay, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Rosenkrands I; Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Juel HB; Novo Nordisk Foundation, Center for Basic Metabolic Research, Copenhagen, Denmark., Delache B; Université Paris-Saclay, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Langlois S; Université Paris-Saclay, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Delaugerre C; Laboratory of Virology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Université de Paris, Paris Cité, Paris, France., Joubert C; Université Paris-Saclay, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Dereuddre-Bosquet N; Université Paris-Saclay, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Bébéar C; Bordeaux University Hopsital, Bacteriology Department, National Reference Centre for bacterial Sexually Transmitted Infections, Bordeaux, France., De Barbeyrac B; Bordeaux University Hopsital, Bacteriology Department, National Reference Centre for bacterial Sexually Transmitted Infections, Bordeaux, France., Touati A; Bordeaux University Hopsital, Bacteriology Department, National Reference Centre for bacterial Sexually Transmitted Infections, Bordeaux, France., McKay PF; Department of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom., Shattock RJ; Department of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom., Le Grand R; Université Paris-Saclay, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Follmann F; Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Dietrich J; Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark. |
